Volume 5, Issue 2 (9-2018)                   NBR 2018, 5(2): 144-154 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Oloumi H, Nasibi F, Mozaffari H. Investigation of the growth rate and secondary metabolites content of Lepidium sativum under exogenous melatonin treatment. NBR 2018; 5 (2) :144-154
URL: http://nbr.khu.ac.ir/article-1-2903-en.html
, Graduate University of Advanced Technology , oloumi.ha@gmail.com
Abstract:   (5607 Views)

Medicinal plants are rich sources of secondary metabolites. Lepidium sativum possess active compounds and secondary metabolites, including polyphenol, anthocyanin, flavonoid compounds, which are of special pharmaceutical and economic importance. Melatonin as bio-stimulator compound has a regulatory role on the amount of secondary metabolites and plant tolerance to environmental stresses. In this study, the effect of exogenous melatonin on secondary metabolites production on Lepidium sativum plants was carried out in a completely randomized design with 5 melatonin treatments (0, 5, 10, 50 and 100 μM) and 3 replications. After applying the treatment, the growth rate and content of the photosynthetic pigments, the leaf water content, as well as the content of flavonoids, anthocyanins and total phenolic compounds were investigated. Seed treatment with melatonin, especially at concentrations of 50 and 100 μM, improved the growth parameters and content of photosynthetic pigments. High levels of melatonin also increased the plant's secondary metabolites, including anthocyanins, carotenoids, and plant phenolic compounds. These effects can confirm the role of melatonin as a growth regulator and its impact on plant growth and resistance.

Full-Text [PDF 774 kb]   (1782 Downloads)    
Type of Study: Original Article | Subject: Plant Biology
Received: 2017/07/16 | Revised: 2021/06/1 | Accepted: 2018/09/22 | Published: 2018/09/22 | ePublished: 2018/09/22

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Nova Biologica Reperta

Designed & Developed by : Yektaweb